441016-97-3Relevant articles and documents
HEXAHYDROPENTALENO DERIVATIVES, PREPARATION METHOD AND USE IN MEDICINE THEREOF
-
Paragraph 0157; 0161, (2015/05/06)
The invention relates to hexahydropentaleno derivatives, the preparation method and use in medicine thereof, and in particular to hexahydropentaleno derivatives or stereo-isomers or pharmaceutically acceptable salts thereof as shown in general formula (I), and to the preparation method therefor and pharmaceutical compositions comprising the derivatives, and to the use thereof as a therapeutical agent, especially as a DPP-IV inhibitor. The definition of each substituent in formula (I) is the same as the definition in the description.
Synthesis and biological evaluation of bicyclo[3.3.0] octane derivatives as dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes
Cho, Tang Peng,Gang, Lin Zhi,Long, Yang Fang,Yang, Wang,Qian, Wang,Lei, Zhang,Jing, Luo Jing,Ying, Feng,Ke, Yan Pang,Ying, Leng,Jun, Feng
scheme or table, p. 3521 - 3525 (2010/08/20)
A series of novel bicyclo[3.3.0]octane derivatives have been synthesized and found to be dipeptidyl peptidase 4 (DPP-4) inhibitors. Compounds 10a and 10b demonstrate good efficacies in oral glucose tolerance tests.
Dicyclooctane Derivatives, Preparation Processes and Medical Uses Thereof
-
Page/Page column 34, (2009/07/18)
The present invention relates to new dicyclooctane derivates represented by general formula (I), preparation processes and pharmaceutical compositions containing them, and to uses for treatment especially for dipeptidyl peptidase inhibitor (DPPIV), in which each substituent group of general formula (I) is as defined in specification.
DICYCLOOCTANE DERIVATES, PREPARATION PROCESSES AND MEDICAL USES THEREOF
-
Page/Page column 42-43, (2009/01/24)
The present invention relates to new dicyclooctane derivates represented by general formula (I), preparation processes and pharmaceutical compositions containing them, and to uses for treatment especially for dipeptidyl peptidase inhibitor (DPPIV), in which each substituent group of general formula (I) is as defined in specification
An enantiodivergent trend in microbial Baeyer-Villiger oxidations of functionalized pentalenones by recombinant whole cells expressing monooxygenases from Acinetobacter and Pseudomonas
Mihovilovic, Marko D.,Mueller, Bernhard,Schulze, Alexander,Stanetty, Peter,Kayser, Margaret M.
, p. 2243 - 2249 (2007/10/03)
We have investigated the microbial Baeyer-Villiger oxidations of pentalenones by recombinant whole cells expressing cyclohexanone monooxygenase from Acinetobacter and cyclopentanone monooxygenase from Pseudomonas. The two enzymes display a distinguishable
Whole-cell mediated Baeyer-Villiger oxidation of functionalized bicyclo[3.3.0]ketones by recombinant E. coli
Mihovilovic, Marko D.,Müller, Bernhard,Kayser, Margaret M.,Stewart, Jon D.,Stanetty, Peter
, p. 703 - 706 (2007/10/03)
Recombinant whole cells of Escherichia coli overexpressing Acinetobacter sp. NCIMB 9871 cyclohexanone monooxygenase (E.C. 1.14.13.22) have been utilized for the Baeyer-Villiger oxidation of functionalized bicyclo[3.3.0]ketones. Prochiral substrates were d